Takehito Takeuchi
Overview
Explore the profile of Takehito Takeuchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
81
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Honda H, Hashimoto N, Zenibayashi M, Takeda A, Takeuchi T, Yamamoto A, et al.
Diabetol Int
. 2025 Jan;
16(1):30-38.
PMID: 39877439
Objective: To examine the validity of the International Physical Activity Questionnaire short form (IPAQ-SF) against an objective method for assessing physical activity (PA) in Japanese adults with type 1 diabetes...
2.
Nishikage S, Hirota Y, Takayoshi T, Yoshimura K, Takeuchi T, Hamaguchi T, et al.
J Clin Endocrinol Metab
. 2025 Jan;
PMID: 39873375
Objective: Type A insulin resistance syndrome (IRS), characterized by impaired insulin receptor function due to variants of the insulin receptor gene, manifests as severe insulin-resistant diabetes. Differentiation of type A...
3.
Nishimoto Y, Hashimoto N, Kido N, Irahara A, Takeuchi T, Takabe M, et al.
J Clin Biochem Nutr
. 2024 Nov;
75(3):213-216.
PMID: 39583973
Type 1 diabetes mellitus (T1DM) may be associated with other autoimmune diseases. Celiac disease (CD), another autoimmune disorder that mainly affects the small intestine, is caused by intolerance to gluten...
4.
Nakagawa Y, Hirota Y, Yamamoto A, Takayoshi T, Takeuchi T, Hamaguchi T, et al.
Kobe J Med Sci
. 2023 Jan;
68(1):E5-E10.
PMID: 36647081
Among continuous glucose monitoring (CGM) devices, which continuously measure glucose concentration in subcutaneous interstitial fluid for comprehensive monitoring of blood glucose profile, only FreeStyle Libre Pro® (Abbott Diabetes Care) is...
5.
Takeuchi T, Hirota Y, Nakagawa Y, Matsuoka A, Hamaguchi T, Okada Y, et al.
Diabetol Int
. 2022 Jan;
13(1):226-231.
PMID: 35059259
Patients with diabetes mellitus having insulin antibodies (InsAb) with properties of high binding capacity and low affinity, which are observed in insulin autoimmune syndrome (IAS), are known to have greater...
6.
Takeuchi T, Ishigaki Y, Hirota Y, Hasegawa Y, Yorifuji T, Kadowaki H, et al.
J Diabetes Investig
. 2019 Nov;
11(3):603-616.
PMID: 31677333
Aims/introduction: Insulin resistance syndrome (IRS) of type A or B is triggered by gene abnormalities of or autoantibodies to the insulin receptor, respectively. Rabson-Mendenhall/Donohue syndrome is also caused by defects...
7.
Matsuoka A, Hirota Y, Takeda A, Kishi M, Hashimoto N, Ohara T, et al.
J Diabetes Investig
. 2019 Aug;
11(2):417-425.
PMID: 31461223
Aims/introduction: Sulfonylurea-related hypoglycemia increases the risk of cardiovascular sequela, such as cardiac arrhythmia. This study aimed to clarify the relationship between the level of glycated hemoglobin (HbA ) and the...
8.
Hozumi K, Fukuoka H, Odake Y, Takeuchi T, Uehara T, Sato T, et al.
Endocr J
. 2019 Jun;
66(10):853-857.
PMID: 31189769
Although acromegaly has been reported in patients with Neurofibromatosis type 1 (NF1), these cases have not been associated with growth hormone (GH)-producing somatotroph adenoma, but with optic pathway glioma. A...
9.
Matsuoka A, Hirota Y, Urai S, Hamaguchi T, Takeuchi T, Miura H, et al.
Diabetol Int
. 2019 Jan;
9(3):201-207.
PMID: 30603368
Aims: Evidence suggests that sensor augmented pump (SAP) therapy is superior to conventional continuous subcutaneous insulin infusion (CSII) for achieving glycemic control in patients with type 1 diabetes. However, the...
10.
The prescription rates of glucagon for hypoglycemia by pediatricians and physicians are low in Japan
Matsumoto M, Awano H, Hirota Y, Nagai M, Bo R, Matsuoka A, et al.
Endocrine
. 2018 Oct;
64(2):233-238.
PMID: 30367442
Purpose: Hypoglycemia is a common and life-threatening complication in type 1 diabetes mellitus (T1DM) patients. Current guidelines recommend glucagon for treating hypoglycemia in out-of-hospital settings; however, glucagon is reportedly underused...